GEMMA Biotherapeutics—a new therapeutics company founded by gene therapy pioneer Dr. Jim Wilson—has named May Orfali, MD, MBA, as Chief Medical Officer. Dr. Orfali brings nearly three decades of experience in clinical development and medical affairs. She has expertise in multiple therapeutic areas, including oncology, infectious diseases, and rare and orphan diseases. She has led clinical development, clinical operations, biostatistics, medical affairs, patient affairs, and regulatory and str...